RPH联合直肠黏膜硬化剂注射法治疗直肠黏膜内脱垂的临床疗效分析

Clinial Effect Analysis of Internal Rectal Mucosa Prolapse Treated with RPH and Sclerosing Agent Injection

为探讨RPH联合直肠黏膜硬化剂注射法治疗直肠黏膜内脱垂的临床疗效,将我科2016年1月至2017年12月收治的66例直肠黏膜内脱垂患者按随机数字表法分为研究组和对照组,每组33例,研究组采用RPH联合直肠黏膜硬化剂注射法治疗,对照组采用手法结扎或切除直肠黏膜联合硬化剂注射法治疗。比较2组患者近期疗效、远期疗效及患者满意度。结果显示,研究组术后肛门坠胀感、粪便梗阻感、排便不尽感缓解情况均优于对照组,差异有统计学意义,P <0.05。术后随访6个月,研究组总体疗效和患者满意度均显著优于对照组,差异均有统计学意义,P <0.05。结果表明,RPH联合直肠黏膜硬化剂注射法治疗直肠黏膜内脱垂疗效显著,可有效缓解临床症状,值得临床推广应用。

To investigate the effect of internal rectal mucosa prolapse（1RMP） treated with RPH and scle- rosing agent（SA） injection,66 IRMP patients who were admitted and received treatment in author＇s dept. （2016-01--2017-12） were randomly divided into research group （ n =33,RPH＋SA injection） and control one（ n =33 ,maneuver ligation or resection for rectal mucosa,plus SA injection）,then both groups′ short, long-term effect and patients′ satisfactory degree.As results, in the alleviation of anal tenesmus sensation, of stool-obstructed sensation,and of unended sensation for bowel movement research group was all superior to control one（ P〈0.05） ;and the follow-up of 6 months showed the total effect and patients＂ satisfactory degree of research group were significantly superior to that of control one, there was all statistical differ- ence（ P〈0.05）.Results show that RPH plus SA injection for treating IRMP has significant effect,can ef- fectively reduce symptom.It is worthy of clinical popularization and application.